Solitary Hepatic VX2 Tumor Model and Its CT Findings in Rabbits

가토에서 VX2 단일간암모델과 CT 소견

  • Lee, Hae-Beom (College of Veterinary Medicine, Chonbuk National University) ;
  • Lee, Ki-Chang (College of Veterinary Medicine, Chonbuk National University)
  • Published : 2006.12.30

Abstract

To verify the solitary nodular hepatocellular tumor model induced by intraparenchymal VX2 tumor cell injection and assess the diagnostic imaging character by computed tomography in rabbits. The tumor cell fragment ($1{\sim}2mm^3$) was loaded in Seldinger needle and directly implanted into the livers of 80 New Zealand white rabbits. The tumor size and patterns of tumor growth were evaluated using spiral computed tomography (CT) at 1, 2, and 3 weeks after tumor implantation. A solitary nodular tumor was successfully created in 82.5% (66/80). The mortality rate was 5% (4/80). The tumor sizes measured were 7.46.3, 14.210.8, 16.212.6 cm at 1, 2, and 3 weeks after tumor implantation on arterial phase CT images. The tumors were round to oval shape with peripheral enhancement and central hypoattenuation on arterial phase, and hypoatteuated wash-out pattern on portal phase. It is considered that inoculation of tumor fragment loaded in Seldinger needle is useful and practical method for creating a solitary hepatic tumor. And CT scanning are valuable to investigate the hepatic tumor and compatible to the observations on macro-and microscopic findings.

80두의 가토 간에 $1{\sim}2mm^3$ 크기의 VX2 종양세포를 직접 주입하여 단일간암모델을 만들고, 종양이식 후1주, 2주, 3주째에 CT촬영을 실시하여 생성된 종양의 크기와 조영 양상을 관찰하고 조직병리학적검사로 종양의 진위 여부를 확인하였다. 80두 중 66두(82.5%)에서 단일 종양이 만들어졌다. 나머지 12두 중 1두에서 간외종앙의 생성, 그리고 다른 1두에서 육아종성 종괴가 관찰되었으며, 4두는 폐사하였다. 나머지 8두에서는 종양이 생성되지 않았다. 조영 CT에서 관찰된 종양의 크기는 1주, 2주 그리고 3주째에 각각 $7.4{\times}6.3,\;14.2{\times}10.8,\;16.2{\times}12.6cm$로 측정되었다. 모양은 둥글거나 타원형이었으며, 동맥기에서 중앙에 저감쇠와 변연에 조영증강을 보였으며, 문맥기에는 저감쇠를 나타내었다. 종양조직의 이식은 균질한 단일종양모델을 만드는데 매우 유용하고 적합한 방법이며, 조영 CT 촬영술은 간종양 진단 및 다양한 치료방법 적용 후 추적검사에 매우 유용하게 활용될 것으로 판단된다.

Keywords

References

  1. Bonte FJ, Curry GC, Parkey RW. Experimental studies of the splanchnic circulation of the rabbit after ligation of the superior mesenteric artery. I. Angiographic and physiologic studies. Am J Roentgenol Radium Ther Nucl Med 1969; 106: 691-699 https://doi.org/10.2214/ajr.106.4.691
  2. Burgener FA, Violante MR. Comparison of hepatic VX2-carcinomas after intra-arterial, intraportal and intraparenchymal tumor cell injection. An angiographic and computed tomographic study in the rabbit. Invest Radiol 1979; 14: 410-414 https://doi.org/10.1097/00004424-197909000-00005
  3. Chen MC, Tsang YM, Stark DD, Weissleder R, Saini S, Brandhorst J, White DL, Engelstad BL, Ferrucci JT. Hepatic metastases: rat models for imaging research. Magn Reson Imaging 1989; 7: 1-8 https://doi.org/10.1016/0730-725X(89)90318-4
  4. Choi BI, Lee DH, Han MC. Necrotic areas in VX2 carcinoma of rabbits. Correlation of magnetic resonance imaging and pathologic appearance. Invest Radiol 1993; 28:33-38 https://doi.org/10.1097/00004424-199301000-00010
  5. Izumi B, Tashiro S, Miyauchi Y. Anticancer effects of local administration of mitomycin C via the hepatic artery or portal vein on implantation and growth of VX2 cancer injected into rabbit liver. Cancer Res 1986; 46: 4167-4170
  6. Kidd JG, Rous P. A transplantable rabbit carcinoma originating in a virus-induced papilloma and containing the virus in masked or altered form. J Exp Med 1940; 71: 813-837 https://doi.org/10.1084/jem.71.6.813
  7. Lin WY, Chen J, Lin Y, Han K. Implantation of VX2 carcinoma into the liver of rabbits: a comparison of three direct-injection methods. J Vet Med Sci 2002; 64: 649-652 https://doi.org/10.1292/jvms.64.649
  8. Nakakuma K, Tashiro S, Hiraoka T, Ogata K, Ootsuka K. Hepatocellular carcinoma and metastatic cancer detected by iodized oil. Radiology 1985; 154: 15-17 https://doi.org/10.1148/radiology.154.1.2981111
  9. Nishizaki T, Matsumata T, Kanematsu T, Yasunaga C, Sugimachi K. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis. J Surg Res 1990; 49: 92-97 https://doi.org/10.1016/0022-4804(90)90116-J
  10. Rougier P, Munck JN, Elias D, Herait P, Bognel C, Gosse C, Lasser P. Intra-arterial hepatic chemotherapy with pirarubicin. Preclinical and clinical studies. Am J Clin Oncol 1990; 13: 1-4 https://doi.org/10.1097/00000421-199012001-00001
  11. Shope RE, Hurst EW. Infectious papillomatosis of rabbits; with a note on the histopathology. J Exp Med 1933; 58: 607-624 https://doi.org/10.1084/jem.58.5.607
  12. Tabuchi Y, Nakamura T, Saitoh Y. Liver metastases induced by implantation of VX2 cancer into the gastrointestine. J Surg Res 1991; 50: 216-222 https://doi.org/10.1016/0022-4804(91)90181-K
  13. Tamura Y, Sakata Y, Tsushima K, Narushima S, Yamada Y, Ogasawara H, Ito T, Saitoh S, Suzuki H, Yoshida Y. A novel model of solitary hepatic tumor in rats using ascites hepatoma AH13: suitability for chemotherapeutic studies. Jpn J Cancer Res 1990; 81: 1045-1051 https://doi.org/10.1111/j.1349-7006.1990.tb03344.x
  14. Thorstensen O, Isberg B, Svahn U, Jorulf H, Venizelos N, Jaremko G. Experimental tissue transplantation using a biopsy instrument and radiologic methods. Invest Radiol 1994; 29: 469-471 https://doi.org/10.1097/00004424-199404000-00015
  15. Violante MR, Dean PB. Improved detectability of VX2 carcinoma in the rabbit liver with contrast enhancement in computed tomography. Radiology 1980; 134: 237-239 https://doi.org/10.1148/radiology.134.1.7350611
  16. Wolf W, Presant CA, Servis KL, el-Tahtawy A, Albright MJ, Barker PB, Ring R 3rd' Atkinson D, Ong R, King M, Singh M, Ray M, Wiseman C, Blayney D, Shani J. Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits. Proc Natl Acad Sci USA 1990; 87: 492-496 https://doi.org/10.1073/pnas.87.1.492
  17. Yang R, Rescorla FJ, Reilly CR, Faught PR, Sanghvi NT, Lumeng L, Franklin TD Jr, Grosfeld JL. A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. J Surg Res 1992; 52: 193-198 https://doi.org/10.1016/0022-4804(92)90072-8